Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice

Beneficial Microbes

Volumn 5, Issue 4, 2014, Pages 437-445

  Stenman, L K ^a   Waget, A ^b   Garret, C ^b   Klopp, P ^b   Burcelin, R ^b   Lahtinen, S ^a  

^a DUPONT COMPANY   (United States)

^b CHU RANGUEIL   (France)

Author keywords

Diabetes; Intestinal permeability; Mice; Obesity; Probiotics

Indexed keywords

LIPOPOLYSACCHARIDE; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM ADHERENCE; BIFIDOBACTERIUM ANIMALIS; BODY COMPOSITION; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG RESEARCH; ESCHERICHIA COLI; FAT MASS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; MALE; MOUSE; NONHUMAN; OBESITY; WEIGHT GAIN; ANIMAL; BIFIDOBACTERIUM; C57BL MOUSE; MOUSE MUTANT; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; BIFIDOBACTERIUM; BODY COMPOSITION; GLUCOSE INTOLERANCE; MALE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PROBIOTICS; TREATMENT OUTCOME;

EID: 84907030443     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2014.0014     Document Type: Article

References (35)

1. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez-Humaran, L.G., Smirnova, N., Berge, M., Sulpice, T., Lahtinen, S., Ouwehand, A., Langella, P., Rautonen, N., Sansonetti, P.J. and Burcelin, R., 2011. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 3: 559-572.
2. Andreasen, A.S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R.M., Moller, K., Svendsen, K.D., Jakobsen, M. and Pedersen, B.K., 2010. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. British Journal of Nutrition 104: 1831-1838.
3. Asemi, Z., Samimi, M., Tabassi, Z., Naghibi Rad, M., Rahimi Foroushani, A., Khorammian, H. and Esmaillzadeh, A., 2013. Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial. European Journal of Clinical Nutrition 67: 71-74.
4. Backhed, F., Manchester, J.K., Semenkovich, C.F. and Gordon, J.I., 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the USA 104: 979-984.
5. Bermudez-Brito, M., Plaza-Diaz, J., Munoz-Quezada, S., Gomez-Llorente, C. and Gil, A., 2012. Probiotic mechanisms of action. Annals of Nutrition and Metabolism 61: 160-174.
6. Burcelin, R., Crivelli, V., Dacosta, A., Roy-Tirelli, A. and Thorens, B., 2002. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. American Journal of Physiology: Endocrinology and Metabolism 282: E834-E842.
7. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
8. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
9. Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., Gibson, G.R. and Delzenne, N.M., 2007b. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
10. Cano, P.G., Santacruz, A., Trejo, F.M. and Sanz, Y., 2013. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity 21: 2310-2321.
11. Carvalho, B.M., Guadagnini, D., Tsukumo, D.M., Schenka, A.A., Latuf-Filho, P., Vassallo, J., Dias, J.C., Kubota, L.T., Carvalheira, J.B. and Saad, M.J., 2012. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55: 2823-2834.
12. Chen, J.J., Wang, R., Li, X.F. and Wang, R.L., 2011. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Experimental Biology and Medicine 236: 823-831.
13. Collado, M.C., Meriluoto, J. and Salminen, S., 2007. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology 45: 454-460.
14. De la Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C. and Raybould, H.E., 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American Journal of Physiology: Gastrointestinal and Liver Physiology 299: G440-G448.
15. Everard, A., Geurts, L., Van Roye, M., Delzenne, N.M. and Cani, P.D., 2012. Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PloS One 7: e33858.
16. Ghoshal, S., Witta, J., Zhong, J., de Villiers, W. and Eckhardt, E., 2009. Chylomicrons promote intestinal absorption of lipopolysaccharides. Journal of Lipid Research 50: 90-97.
17. Hotamisligil, G.S., 2006. Inflammation and metabolic disorders. Nature 444: 860-867.
18. Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M. and Tsuchida, T., 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 64: 636-643.
19. Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., Ikuyama, K., Kagoshima, M. and Tsuchida, T., 2013. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition 110: 1696-1703.
20. Keita, A.V., Salim, S.Y., Jiang, T., Yang, P.C., Franzen, L., Soderkvist, P., Magnusson, K.E. and Soderholm, J.D., 2008. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. Journal of Pathology 215: 135-144.
21. Kim, K.A., Gu, W., Lee, I.A., Joh, E.H. and Kim, D.H., 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PloS One 7: e47713.
22. Kim, S.W., Park, K.Y., Kim, B., Kim, E. and Hyun, C.K., 2013. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochemical and Biophysical Research Communications 431: 258-263.
23. Kondo, S., Xiao, J.Z., Satoh, T., Odamaki, T., Takahashi, S., Sugahara, H., Yaeshima, T., Iwatsuki, K., Kamei, A. and Abe, K., 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience, Biotechnology, and Biochemistry 74: 1656-1661.
24. Luche, E., Cousin, B., Garidou, L., Serino, M., Waget, A., Barreau, C., Andre, M., Valet, P., Courtney, M., Casteilla, L. and Burcelin, R., 2013. Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Molecular Metabolism 2: 281-291.
25. Muccioli, G.G., Naslain, D., Backhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M. and Cani, P.D., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 6: 392.
26. Park, D.Y., Ahn, Y.T., Park, S.H., Huh, C.S., Yoo, S.R., Yu, R., Sung, M.K., McGregor, R.A. and Choi, M.S., 2013. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PloS One 8: e59470.
27. Pussinen, P.J., Havulinna, A.S., Lehto, M., Sundvall, J. and Salomaa, V., 2011. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34: 392-397.
28. Putaala, H., Salusjarvi, T., Nordstrom, M., Saarinen, M., Ouwehand, A.C., Bech Hansen, E. and Rautonen, N., 2008. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Research in Microbiology 159: 692-698.
29. Rabot, S., Membrez, M., Bruneau, A., Gerard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R. and Chou, C.J., 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 24: 4948-4959.
30. Sato, M., Uzu, K., Yoshida, T., Hamad, E.M., Kawakami, H., Matsuyama, H., Abd El-Gawad, I.A. and Imaizumi, K., 2008. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. British Journal of Nutrition 99: 1013-1017.
31. Schertzer, J.D., Tamrakar, A.K., Magalhaes, J.G., Pereira, S., Bilan, P.J., Fullerton, M.D., Liu, Z., Steinberg, G.R., Giacca, A., Philpott, D.J. and Klip, A., 2011. NOD1 activators link innate immunity to insulin resistance. Diabetes 60: 2206-2215.
32. Serino, M., Luche, E., Gres, S., Baylac, A., Berge, M., Cenac, C., Waget, A., Klopp, P., Iacovoni, J., Klopp, C., Mariette, J., Bouchez, O., Lluch, J., Ouarne, F., Monsan, P., Valet, P., Roques, C., Amar, J., Bouloumie, A., Theodorou, V. and Burcelin, R., 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61: 543-553.
33. Stenman, L.K., Holma, R., Eggert, A. and Korpela, R., 2013. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. American Journal Physiology: Gastrointestinal and Liver Physiology 304: G227-G234.
34. Stenman, L.K., Holma, R. and Korpela, R., 2012. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World Journal of Gastroenterology 18: 923-929.
35. Yadav, H., Lee, J.H., Lloyd, J., Walter, P. and Rane, S.G., 2013. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry 288: 25088-25097.